Oncocin

General Information


DRACP ID  DRACP03555

Peptide Name   Oncocin

Sequence  VDKPPYLPRPRPPRRIYNR

Sequence Length  19

UniProt ID  A0A2R7WNA0 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03555

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C109H176N36O25

Absent amino acids  ACEFGHMQSTW

Common amino acids  P

Mass  271203

Pl  11.95

Basic residues  6

Acidic residues  1

Hydrophobic residues  3

Net charge  5

Boman Index  -8191

Hydrophobicity  -174.21

Aliphatic Index  56.32

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  2980

Absorbance 280nm  165.56

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Design and Characterization of a Novel Hybrid Antimicrobial Peptide OM19R Based on Oncocin and MDAP-2

Doi Not available

Year  2019

Literature 2

Pubmed ID 26334348

Title  Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus

Doi Not available

Year  2016

Literature 3

Pubmed ID 31105969

Title  Systematic Mutagenesis of Oncocin Reveals Enhanced Activity and Insights into the Mechanisms of Antimicrobial Activity

Doi Not available

Year  2018

Literature 4

Pubmed ID 21185160

Title  Bactericidal oncocin derivatives with superior serum stabilities

Doi Not available

Year  2011

Literature 5

Pubmed ID 25730460

Title  Hydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates

Doi Not available

Year  2015

Literature 6

Pubmed ID 20565063

Title  Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens

Doi Not available

Year  2010

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  7484

DRACP is developed by Dr.Zheng's team.